23 October 2023
23 October 2023
Quantum computing has emerged from its initial hype with continued investment and governments around the world committing to the development of this novel technology.
The Phase III trial of Padcev has reduced the risk of death by 53% against chemotherapy as part of Astella and Seagen’s KEYNOTE-A39 trial.
Speaking to Clinical Trials Arena, Olema CEO Sean Bohen said that the first patient in Phase III will be dosed before the end of 2023.
Many businesses in the West are vulnerable to technology espionage because they don’t have adequate cyber hygiene, according to experts.
Filippo Bonsanti, VP of global marketing at Indeed, said that every job will be transformed by AI in some way.
Leading Surgical robotics manufacturer Intuitive Surgical's shares dropped 8% in pre-market trading following the results.
Swiss-based company Roche has discontinued an oral diabetic retinopathy treatment after having cleared Phase II studies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
